Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000635523 | SCV000756937 | likely benign | Juvenile polyposis syndrome | 2024-09-21 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000773231 | SCV000906843 | likely benign | Hereditary cancer-predisposing syndrome | 2018-07-17 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000773231 | SCV001170652 | likely benign | Hereditary cancer-predisposing syndrome | 2019-11-20 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV003478356 | SCV004222518 | likely benign | not provided | 2023-09-15 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV000635523 | SCV004835990 | likely benign | Juvenile polyposis syndrome | 2023-08-15 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV000635523 | SCV005406375 | benign | Juvenile polyposis syndrome | 2024-08-07 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |